AAAAAA
Results: 1-25/26
Authors:
Baron, AT
Lafkyk, JM
Suman, VJ
Hillman, DW
Buenafe, MC
Boardman, CH
Podratz, KC
Perez, EA
Maihle, NJ
Citation: At. Baron et al., A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women, CANC EPID B, 10(11), 2001, pp. 1175-1185
Authors:
Perez, EA
Citation: Ea. Perez, Adjuvant anti-HER2 monoclonal antibody therapy - ready for breast cancer?, BREAST, 10, 2001, pp. 161-163
Authors:
Perez, EA
Citation: Ea. Perez, Doxorubicin and paclitaxel in the treatment of advanced breast cancer: Efficacy and cardiac considerations, CANCER INV, 19(2), 2001, pp. 155-164
Authors:
Perez, EA
Vogel, CL
Irwin, DH
Kirshner, JJ
Patel, R
Citation: Ea. Perez et al., Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer, J CL ONCOL, 19(22), 2001, pp. 4216-4223
Authors:
Lara, PN
Gandara, DR
Longmate, J
Gumerlock, PH
Martin, DHML
Edelman, J
Gandour-Edwards, R
Mack, PC
Israel, V
Raschko, J
Frankel, P
Perez, EA
Lenz, HJ
Doroshow, JH
Citation: Pn. Lara et al., Activity of high-dose toremifene plus cisplatin in platinum-treated nonsmall-cell lung cancer: a phase II California Cancer Consortium Trial, CANC CHEMOT, 48(1), 2001, pp. 22-28
Authors:
Hortobagyi, GN
Perez, EA
Citation: Gn. Hortobagyi et Ea. Perez, Integration of trastuzumab into adjuvant systemic therapy of breast cancer: Ongoing and planned clinical trials, SEMIN ONCOL, 28(5), 2001, pp. 41-46
Authors:
Perez, EA
Citation: Ea. Perez, Metastatic bone disease in breast cancer: The patient's perspective, SEMIN ONCOL, 28(4), 2001, pp. 60-63
Role of axillary node dissection in patients with T1a and T1b breast cancer - Mayo Clinic experience
Authors:
Mincey, BA
Bammer, T
Atkinson, EJ
Perez, EA
Citation: Ba. Mincey et al., Role of axillary node dissection in patients with T1a and T1b breast cancer - Mayo Clinic experience, ARCH SURG, 136(7), 2001, pp. 779-782
Authors:
Bonner, JA
Sloan, JA
Rowland, KM
Klee, GG
Kugler, JW
Mailliard, JA
Wiesenfeld, M
Krook, JE
Maksymiuk, AW
Shaw, EG
Marks, RS
Perez, EA
Citation: Ja. Bonner et al., Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer, CLIN CANC R, 6(2), 2000, pp. 597-601
Authors:
Hesketh, PJ
Roman, A
Hesketh, AM
Perez, EA
Edelman, M
Gandara, DR
Citation: Pj. Hesketh et al., Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen, SUPP CARE C, 8(1), 2000, pp. 46-48
Authors:
Perez, EA
Sampol, CJ
Citation: Ea. Perez et Cj. Sampol, Tourist expenditure for mass tourism markets, ANN TOURISM, 27(3), 2000, pp. 624-637
Authors:
Perez, EA
Hortobagyi, GN
Citation: Ea. Perez et Gn. Hortobagyi, Ongoing and planned adjuvant trials with trastuzumab, SEMIN ONCOL, 27(6), 2000, pp. 26-32
Authors:
Mincey, BA
Moraghan, TJ
Perez, EA
Citation: Ba. Mincey et al., Prevention and treatment of osteoporosis in women with breast cancer, MAYO CLIN P, 75(8), 2000, pp. 821-829
Authors:
Loprinzi, CL
Alberts, SR
Christensen, BJ
Hanson, LJ
Farley, DR
Broers, JK
Betcher, DL
Grady, RE
Southorn, PA
Johnson, TM
Perez, EA
Citation: Cl. Loprinzi et al., History of the development of antiemetic guidelines at Mayo Clinic Rochester, MAYO CLIN P, 75(3), 2000, pp. 303-309
Authors:
Perez, EA
Hillman, DW
Stella, PJ
Krook, JE
Hartmann, LC
Fitch, TR
Hatfield, AK
Mailliard, JA
Nair, S
Kardinal, CG
Ingle, JN
Citation: Ea. Perez et al., A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma, CANCER, 88(1), 2000, pp. 124-131
Authors:
Ingle, JN
Suman, VJ
Johnson, PA
Krook, JE
Mailliard, JA
Wheeler, RH
Loprinzi, CL
Perez, EA
Jordan, VC
Dowsett, M
Citation: Jn. Ingle et al., Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer, CLIN CANC R, 5(7), 1999, pp. 1642-1649
Authors:
Perez, EA
Tiemeier, T
Solberg, LA
Citation: Ea. Perez et al., Antiemetic therapy for high-dose chemotherapy with transplantation: reportof a retrospective analysis of a 5-HT3 regimen and literature review, SUPP CARE C, 7(6), 1999, pp. 413-424
Authors:
Gralla, RJ
Osoba, D
Kris, MG
Kirkbride, P
Hesketh, PJ
Chinnery, LW
Clark-Snow, R
Gill, DP
Groshen, S
Grunberg, S
Koeller, JM
Morrow, GR
Perez, EA
Silber, JH
Pfister, DG
Citation: Rj. Gralla et al., Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines, J CL ONCOL, 17(9), 1999, pp. 2971-2994
Authors:
Perez, EA
Citation: Ea. Perez, Doxorubicin cardiotoxicity: Growing importance - Reply 2, J CL ONCOL, 17(7), 1999, pp. 2296-2296
Authors:
Perez, EA
Citation: Ea. Perez, Cardiotoxicity associated with paclitaxel trastuzumab combination therapy - Reply, J CL ONCOL, 17(5), 1999, pp. 1648-1648
Authors:
Perez, EA
Citation: Ea. Perez, 5-HT3 antiemetic therapy for patients with breast cancer, BREAST CANC, 57(2), 1999, pp. 207-214
Authors:
Perez, EA
Citation: Ea. Perez, Current management of metastatic breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 1-10
Authors:
Perez, EA
Citation: Ea. Perez, Paclitaxel plus nonanthracycline combinations in metastatic breast cancer, SEMIN ONCOL, 26(1), 1999, pp. 21-26
Authors:
Perez, EA
Reigosa, RP
Seco, AL
Fernandez, FB
Citation: Ea. Perez et al., A case of tizanidine-induced hepatic injury, MED CLIN, 112(12), 1999, pp. 478-479
Authors:
Quella, SK
Loprinzi, CL
Sloan, J
Novotny, P
Perez, EA
Burch, PA
Antolak, SJ
Pisansky, TM
Citation: Sk. Quella et al., Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer, J UROL, 162(1), 1999, pp. 98-102